A
ALT
Altimmune
3.380
+0.010+0.30%Pre Market: 3.440 +0.060 +1.78%08:08 04/10 EDT
OPEN/PREV CLOSE3.350/3.370
TODAY RANGE3.310-3.440
VOL2.49K
MARKET CAP439.76M
52 WEEK RANGE2.870-7.73
AVG VOL (3M)3.95M
% TURNOVER1.53%
TURNOVER0
P/E (TTM)-3.3803
% RANGE3.86%
EPS(TTM)-0.9999
P/E(FORWARD)-3.3137
P/B1.667
BVPS2.028
DIVIDEND--
P/S8,450.00
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP437.01M
SHARES OUTSTANDING130.11M
NEXT EARNINGS05/11-05/15
FREE FLOAT129.29M
LOT SIZE1
EX-DATE09/14/2018
News
Press Releases
Financial Reports
Profile
Seeking Alpha·21h ago
Altimmune: Considering If A Repeat Of The 2025 Run-Up Is On Tap
TipRanks·3d ago
Altimmune Insider Makes Bold New Share Grab
TipRanks·04/02 02:05
Top Altimmune Insiders Quietly Boost Their Stakes in a Big Way
Reuters·04/01 20:06
Altimmune CFO Gregory Weaver acquires $31,499 common shares
Reuters·04/01 20:06
Altimmune CEO Jerome Durso acquires $0.0 million common shares
Reuters·04/01 16:19
BUZZ-Eli Lilly rises after US FDA approves weight-loss pill
Reuters·03/19 06:52
U.S. RESEARCH ROUNDUP-Carnival, Five Below, McKesson
Seeking Alpha·03/18 21:03
Altimmune a new buy at Truist on pemvidutide promise
TipRanks·03/18 20:00
Altimmune initiated with a Buy at Truist
Dow Jones·03/16 16:27
Altimmune Price Target Raised to $25.00/Share From $12.00 by HC Wainwright & Co.
Dow Jones·03/16 16:27
Altimmune Is Maintained at Buy by HC Wainwright & Co.
Benzinga·03/16 16:17
HC Wainwright & Co. Maintains Buy on Altimmune, Raises Price Target to $25
Same Industry
Name/Symbol
Change%
Price